Pharmacovigilance Excellence
Safeguarding Patient Safety Through Science
Protecting patients worldwide through rigorous drug safety
monitoring and adverse event detection
What is Pharmacovigilance?
Detection & Assessment
Identifying adverse drug reactions and safety signals through systematic monitoringCDSCO — Central Drugs Standard Control Organization
Prevention & Protection
Analyzing information from healthcare providers and patients globally
Research & Evaluation
Analyzing information from healthcare providers and patients globally
Core Mission
The Science of Drug Safety
Pharmacovigilance encompasses the collection, monitoring, and evaluation of adverse effects from medications, biologics, and traditional medicines.
Focus: Long-term and short-term side
effects at therapeutic doses
Global Infrastructure
WHO VigiBase
Central repository
aggregating safety reports
from 150+ countries
worldwide
FDA (United States)
Stringent post-market
surveillance and adverse
event reporting systems
EMA & EudraVigilance
European network for
managing and analyzing
safety information
PvPI (India)
National program ensuring
drug safety monitoring
across India
Global Infrastructure
2024 Market Value
Global pharmacovigilance industry baseline
2033-34 Projection
Expected market expansion
Annual Growth (CAGR)
Sustained industry momentum
The pharmacovigilance sector is experiencing unprecedented
growth driven by regulatory demands and technological innovation
Global Infrastructure
Rising ADR Incidence
Increased awareness and reporting of adverse drug reactions globally Complex Drug Pipelines Expanding pharmaceutical
Complex Drug Pipelines
Expanding pharmaceutical
development with novel
therapeutics
Rising ADR Incidence
Increased awareness and reporting of adverse drug reactions globally Complex Drug Pipelines Expanding pharmaceutical
Technology Revolution
AI & Machine Learning
60%+ adoption by pharmaceutical companies for automated case processing
Cloud Platforms
Real-time reporting, global compliance, predictive
analytics
Signal Detection Tools
Advanced algorithms achieving high accuracy in safety monitoring
Python Programming
The Future of Drug Safety Analytics
India: Emerging PV Hub
01
2010: PvPI Launch
Pharmacovigilance Programme of India established under Indian Pharmacopoeia Commission
02
SoPI Partnership
Society of Pharmacovigilance promotes training, conferences, and best practices nationwide
03
August 2024: ADRMS
ADR Monitoring System launched4streamlined IT platform for enhanced reporting
05
Global Outsourcing Hub
Major destination for CRO activities and case processing services
Outsourcing Dynamics
Services Outsourced
Global PV activities delegated to specialized CROs
North America Share
Leading region in total market percentage
India
Fastest-growing regional expansion rate
Career Pathways
Drug Safety Associate
Entry-level case processing and adverse event documentation
PV Associate / Scientist
Advanced analysis, signal detection, regulatory reporting
Case Processing Expert
Specialized expertise in complex safety evaluations and compliance
PV Team Lead
Team oversight, process management, strategic
planning
Chief Medical Officer (CMO)
High-level medical decision-making, regulatory liaison
Risk Management Specialist
Developing and implementing plans to mitigate known risks associated with marketed products.
Medical Information Associate/Specialist
Responsible for providing accurate and timely medical information
The future of pharmacovigilance: automation, data-driven insights, and global harmonization protecting patients worldwide Dysmech Clinical Services (DCS), operate on a two-pronged model focusing on both Clinical Research and Pharmacovigilance services for the pharmaceutical and IT industry and Skill Development/Training for aspiring professionals.
Comprehensive Training Programs
Advanced Diploma in Clinical Research Management
23 comprehensive modules integrating clinical research with pharmacovigilance principles, systems, and global safety standards.
Post Graduate Diploma in Advanced Clinical Research Management
Duration: 1 year | Fees: ₹1,00,000
Complete 33-module program providing in-depth expertise across all aspects of clinical research and pharmacovigilance.
